| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $41.0M | -47.1% |
| Cost of Revenue | $43.1M | -58.5% |
| Gross Profit | -$2.1M | +92.1% |
| R&D Expense | $17.1M | -59.3% |
| SG&A Expense | $49.3M | +18.3% |
| Operating Income | -$82.3M | +38.2% |
| Interest Expense | $16.0M | +64.2% |
| Pre-tax Income | -$73.3M | +45.7% |
| Income Tax | -$20K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.2M | -95.1% |
| Short-term Investments | $6.6M | +0.0% |
| Accounts Receivable | $3.7M | -61.1% |
| Inventory | $50.0M | -17.9% |
| Current Assets | $57.7M | -51.1% |
| Total Assets | $89.2M | -42.0% |
| Current Liabilities | $38.0M | -21.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.7M | +69.1% |
| Capital Expenditures | $9K | -99.1% |
| Investing Cash Flow | $7.8M | -80.0% |
| Financing Cash Flow | $1.5M | -97.5% |
| Free Cash Flow | -$32.7M | +69.4% |
| — |
| Net Income | -$73.3M | +45.8% |
| EPS (Basic) | -$5.77 | -748.5% |
| EPS (Diluted) | -$5.77 | -748.5% |
| Long-term Debt |
| $6.0M |
| -86.4% |
| Total Liabilities | $49.5M | -42.1% |
| Stockholders' Equity | $39.7M | -42.0% |